• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Groupe Forenap - Strategic SWOT Analysis Review Product Image

Groupe Forenap - Strategic SWOT Analysis Review

  • Published: February 2012
  • Region: Global
  • 18 pages
  • GlobalData

FEATURED COMPANIES

  • CHELATEC SAS
  • Fluofarma SA
  • ICDD-sas
  • IDEALP-PHARMA
  • MORE

Groupe Forenap - Strategic SWOT Analysis Review

Summary

Groupe Forenap is a contract research organization (CRO). The Group includes two businesses, namely, Forenap Pharma (Forenap) and Forenap R&D. Forenap is an international CRO engaged in providing a wide range of services for the early steps of development of compounds. It specializes in early drug development and research in neuroscience and manages the development of compounds from preclinical to phase II studies. Forenap’s services are focused on preclinical phases, phase I in all therapeutic areas and Phase IIa for Central Nervous System (CNS) and Cardiovascular compounds. Forenap R&D is dedicated to scientific research. Forenap is headquartered in Rouffach, Alsace, France.

GlobalData’s Groupe Forenap - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive READ MORE >



List of Tables
List of Figures
Section 1 - About the Company
Groupe Forenap - Key Facts
Groupe Forenap - Key Employees
Groupe Forenap - Key Employee Biographies
Groupe Forenap - Major Products and Services
Groupe Forenap - History
Groupe Forenap - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Groupe Forenap - Business Description
Groupe Forenap - SWOT Analysis
SWOT Analysis - Overview
Groupe Forenap - Strengths
Strength - Diversified Service Offerings
Strength - Large Customer Base
Strength - Strategic Collaborations
Groupe Forenap - Weaknesses
Weakness - Private Ownership
Groupe Forenap - Opportunities
Opportunity - Growing Contract Research Outsourcing Industry
Opportunity - Market Potential: Pain
Opportunity - Market Potential: Central Nervous System
Groupe Forenap - Threats
Threat - Competitive Pressures
Threat - Uncertain R&D Outcomes
Threat - Uncertain R&D Outcomes
Threat - Dearth of Skilled Professionals
Groupe Forenap - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Groupe Forenap, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Groupe Forenap, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Groupe Forenap, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Groupe Forenap, Key Facts
Groupe Forenap, Key Employees
Groupe Forenap, Key Employee Biographies
Groupe Forenap, Major Products and Services
Groupe Forenap, History
Groupe Forenap, Key Competitors
Groupe Forenap, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Groupe Forenap, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Groupe Forenap, Recent Deals Summary

List of Figures
Groupe Forenap, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Groupe Forenap, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012

CHELATEC SAS
Fluofarma SA
ICDD-sas
IDEALP-PHARMA
CIT Safety and Health Research Laboratories
SYNEXEL Research International SAS
Institut de Recherche pour le Developpement

Note: Product cover images may vary from those shown

RELATED PRODUCTS